Skip to main content
Clinical Trials/NCT04413786
NCT04413786
Completed
Not Applicable

The Modulatory Effect of Oxytocin on Attentional Processing of Emotional Faces

University of Electronic Science and Technology of China1 site in 1 country60 target enrollmentOctober 14, 2019

Overview

Phase
Not Applicable
Intervention
oxytocin treatment
Conditions
Healthy
Sponsor
University of Electronic Science and Technology of China
Enrollment
60
Locations
1
Primary Endpoint
Response time in reponse to different emotional face targets.
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

To investigate whether intranasal oxytocin (24IU) treatment has a regulatory effect on attentional processing of emotional faces.

Detailed Description

In a placebo-controlled double-blind between-subject design experiment, investigators plan to investigate the effect of oxytocin treatment on attentional processing of emotional faces. Subjects complete questionnaires in Chinese versions before treatment administration, including the Beck Depression Inventory, Autism Spectrum Quotient , Trait Anxiety Inventory, Toronto Alexithymia Scale, Multidimentional Assessment of Interoceptive Awareness. This experiment consists of two tasks including Emotional Face Cue-target Task and Visual Search Task. In the first task, subjects need to make a response to judge the position of target after a cue-target is presented. In the second task, subjects are asked to search the target "U" or inverted "U" placed on the nose of emotional/neutral faces and make an choices based on their oorientation. During these phases, subjects' response accuracy, response time and electrophysiological activity (ERP) are recorded.

Registry
clinicaltrials.gov
Start Date
October 14, 2019
End Date
December 26, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
University of Electronic Science and Technology of China
Responsible Party
Principal Investigator
Principal Investigator

Shuxia Yao

Associate Professor

University of Electronic Science and Technology of China

Eligibility Criteria

Inclusion Criteria

  • Healthy subjects without past or current psychiatric or neurological disorders.

Exclusion Criteria

  • history of head injury
  • medical or psychiatric illness

Arms & Interventions

oxytocin group

male subjects with oxytocin treatment

Intervention: oxytocin treatment

placebo group

male subjects with placebo treatment

Intervention: placebo treatment

Outcomes

Primary Outcomes

Response time in reponse to different emotional face targets.

Time Frame: 1 hour

Response time in discriminating which side (left or right) the emotional face target appear.

N2pc

Time Frame: 1 hour

N2pc is an enhanced negative event-related potential typically elicited at posterior electrodes (e.g., PO7 and PO8) contralateral to the target presented among distractors between 180 and 300 ms after the onset of stimuli. display.

Secondary Outcomes

  • Response accuracy in response to different emotional face targets.(1 hour)

Study Sites (1)

Loading locations...

Similar Trials